Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.

Lee J, Geiss GK, Demirkan G, Vellano CP, Filanoski B, Lu Y, Ju Z, Yu S, Guo H, Bogatzki LY, Carter W, Meredith RK, Krishnamurthy S, Ding Z, Beechem JM, Mills GB.

Mol Cell Proteomics. 2018 Jun;17(6):1245-1258. doi: 10.1074/mcp.RA117.000291. Epub 2018 Mar 12.

2.

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis.

Llanos-Cuentas A, Calderón W, Cruz M, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Bertholet S, Laughlin EM, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Piazza FM.

Vaccine. 2010 Oct 28;28(46):7427-35. doi: 10.1016/j.vaccine.2010.08.092. Epub 2010 Sep 17.

PMID:
20851080
3.

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.

Nascimento E, Fernandes DF, Vieira EP, Campos-Neto A, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Pine SO, Cowgill KD, Reed SG, Piazza FM.

Vaccine. 2010 Sep 14;28(40):6581-7. doi: 10.1016/j.vaccine.2010.07.063. Epub 2010 Aug 3.

PMID:
20688040
4.

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis.

Vélez ID, Gilchrist K, Martínez S, Ramírez-Pineda JR, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Piazza FM.

Vaccine. 2009 Dec 11;28(2):329-37. doi: 10.1016/j.vaccine.2009.10.045. Epub 2009 Oct 30.

PMID:
19879995
5.

Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Goto Y, Bogatzki LY, Bertholet S, Coler RN, Reed SG.

Vaccine. 2007 Oct 16;25(42):7450-8. Epub 2007 Aug 20.

6.
7.

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Goldrath AW, Bogatzki LY, Bevan MJ.

J Exp Med. 2000 Aug 21;192(4):557-64.

8.

Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling.

Norment AM, Bogatzki LY, Gantner BN, Bevan MJ.

J Immunol. 2000 Jan 15;164(2):639-48.

9.

Differential effects of manipulating signaling in early T cell development in intestinal intraepithelial lymphocytes and thymocytes.

Page ST, Bogatzki LY, Hamerman JA, Malissen M, Perlmutter RM, Pullen AM.

Int Immunol. 1999 Feb;11(2):169-77.

PMID:
10069415
10.

Intestinal intraepithelial lymphocytes include precursors committed to the T cell receptor alpha beta lineage.

Page ST, Bogatzki LY, Hamerman JA, Sweenie CH, Hogarth PJ, Malissen M, Perlmutter RM, Pullen AM.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9459-64.

11.

Supplemental Content

Loading ...
Support Center